Intervention to increase naloxone engagement and distribution in community pharmacies

Project Type(s):

Principal Investigator(s):
Co-Investigator(s):

This multi-site study will test the efficacy of an intervention to train and equip pharmacists to provide naloxone, an overdose antidote, to patients using prescribed and illicit opioids, to improve opioid safety and prevent opioid-involved adverse events. The study will carry out a stepped-wedge, cluster randomized trial implemented over five waves, within two chain community pharmacies across four states with varying pharmacy-based naloxone distribution laws: Oregon, Washington, Massachusetts and New Hampshire.

Our specific study aims are to: 1) integrate two successful demonstration research projects into one cohesive educational program (MOON+), 2) evaluate the effectiveness of MOON + on naloxone-related outcomes, and 3) use mixed methods to further explore the impact and implementation of MOON+ and associated factors (e.g., state policy, store policy, region).

Project Period:
April 1, 2019 — April 30, 2022

Funding Type(s):
Federal

Funder(s):
NIDA

Research Program(s):

Geographic Area(s):
Washington

Practice Type(s):
Primary Care

Patient Population(s):
Adults

Targeted Condition(s):
Health disparities